Coronavirus News Roundup: Pfizer and BioNTech Seek FDA Approval, Pediatric Psychiatric Admissions on the Rise in NYC Hospital
Here’s a roundup of the latest coronavirus-related news.
With all Americans over 16 years able to get vaccinated for COVID-19 and the CDC releasing recent changes to guidelines for fully vaccinated individuals, it’s more important than ever to stay up-to-date on COVID-19 headlines.
Here’s a roundup of the latest coronavirus-related news.
Pfizer and BioNTech Seek FDA Approval for COVID-19 Vaccine
Pfizer and BioNTech have initiated rolling submission of their Biologics License Application for full approval of BNT162b2.
Pediatric Admissions of Substance Abuse, Suicide, and Psychosis in a New York City Hospital During the COVID-19 Pandemic
The Bronx experienced one of the highest mortality rates of COVID-19 during the beginning of the pandemic. Some early research suggests that quarantine and school closures had a major psychosocial impact on children during this time. A study presented at the virtual 2021 Pediatric Academic Societies meeting looks at how children and teenagers living in low socioeconomic settings were affected by the pandemic.
Read more on Contemporary Pediatrics
Are Medically Complex Children At Greater Risk of Severe COVID-19?
The medically complex child is often at greater risk of a life-threatening infection than his or her non-complex peers. A study presented at the virtual 2021 Pediatric Academic Societies meeting examines whether the medically complex child is at greater risk of COVID-19.
Read more on Contemporary Pediatrics
Epidemics Within the Pandemic: Shifting Priorities and Opportunities for Addressing Opioid and Mental Health Crises During Covid-19
Deaths by suicide and by substance use disorders have reached epidemic proportions, creating the tragic “perfect storm” of epidemics within a pandemic. A survey conducted by PRECISIONvalue of population health priorities among health systems and health plans since the onset of COVID-19 suggests that while mental health conditions have risen in priority, opioid use disorders have become alarmingly deprioritized.
